Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy
Cancer Immunology, Immunotherapy · 2024
DOI: 10.1007/s00262-024-03718-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Shaoxian Wu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, Jiangsu, China. Hauptthemen laut MEDLINE: Interleukins, Immune Checkpoint Inhibitors, Programmed Cell Death 1 Receptor, Tumor Microenvironment. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Funding Program for Excellent Postdoctoral Talent, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Despite the success of immune checkpoint inhibitors (ICIs) in treating solid tumors, lots of patients remain unresponsive to this therapy. Microwave ablation (MWA) stimulates systemic adaptive immunity against tumor cells by releasing tumor antigens. Additionally, IL-21 has demonstrated importance in stimulating T-cell effector function. The combination of these three therapies—MWA, IL-21, and anti-PD-1 monoclonal antibodies (mAbs)—has yet to be explored in the context of cancer treatment. In this study, we explored the impact of thermal ablation on IL-21R expression in tumor-infiltrating lymphocytes (TILs). Subsequently, we assessed alterations in the tumor microenvironment (TME) and peripheral lymphoid organs. Additionally, we conducted a thorough examination of tumor-infiltrating CD45 + immune cells across various treatment groups using single-cell RNA sequencing (scRNA-seq). Moreover, we determined the potential anti-tumor effects of the triple combination involving MWA, IL-21, and anti-PD-1 mAbs. Our findings revealed that MWA upregulated the expression of IL-21R on various immune cells in the untreated tumors. The combination of MWA with IL-21 exhibited a robust abscopal anti-tumor effect, enhancing the effector function of CD8 + T cells and facilitating dendritic cells' maturation and antigen presentation in the untreated tumor. Notably, the observed abscopal anti-tumor effect resulting from the combination is contingent upon T-cell recirculation, indicating the reliance of systemic adaptive immunity for this treatment regimen. Additionally, the combination of MWA, IL-21, and PD-1 mAbs demonstrated profound abscopal anti-tumor efficacy. Our findings provide support for further clinical investigation into a triple combination therapy involving MWA, IL-21, and ICIs for the treatment of metastatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, Jiangsu, China.
- Jiangsu Engineering Research Center for Tumor Immunotherapy, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, Jiangsu, China.
- Institute of Cell Therapy, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, Jiangsu, China.
- Shanghai Junshi Biosciences Co.,Ltd., Shanghai, 201206, China.
- Anwita Biosciences Inc, San Carlos, CA, 94070, USA.
- Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, 07110, USA.
Förderung
- National Natural Science Foundation of China
- Jiangsu Funding Program for Excellent Postdoctoral Talent
- Natural Science Foundation of Jiangsu Province
- China Postdoctoral Science Foundation
- the Science and Technology Support Plan (Social Development) Project of Changzhou
- the Key R&D Project of Jiangsu Province
- Jiangsu Provincial Medical Key Discipline
Zitieren
APA
Wu, S., Jiang, H., Fang, Z., Wu, Y., Jiao, J., Fang, W., Wu, Y., Lang, Y., Chen, N., Zhong, Z., Chen, L., Zheng, X., Lu, B., & Jiang, J. (2024). Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03718-1
Vancouver
Wu S, Jiang H, Fang Z, Wu Y, Jiao J, Fang W, et al. Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03718-1
BibTeX
@article{Wu2024,
author = {Wu, Shaoxian and Jiang, Hongwei and Fang, Zhang and Wu, You and Jiao, Jing and Fang, Weiwei and Wu, Yue and Lang, Yanyan and Chen, Ning and Zhong, Ziyang and Chen, Lujun and Zheng, Xiao and Lu, Binfeng and Jiang, Jingting},
title = {Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy},
journal = {Cancer Immunology, Immunotherapy},
year = {2024},
doi = {10.1007/s00262-024-03718-1}
}
EUVIMED